Health CDSCO issues advisory to prevent misleading promotion of prescription drugs for obesity March 11, 2026 gopalkumarthakur@gmail.com Activities that exaggerate therapeutic claims, guarantee weight-loss outcomes, or undermine the importance of lifestyle modifications such as diet and physical activity will be treated as misleading promotion Related posts: What India can learn from Maldives’ mother-to-child triple elimination of diseases Shorter, simpler breast cancer treatment: where evidence meets practice Indian scientists discover ‘genetic switch’ inside womb that leads to pregnancy When institutional reliability matters: the story of di-ethylene glycol
